×

Cookie Settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our privacy policy.

Please make your personal preference here:

Imprint

 
 
Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4030748
Return to Previous Page
4030748

Availability: In stock

Anthranilyl-HIV Protease Substrate trifluoroacetate salt
Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH₂ trifluoroacetate salt

4030748

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4030748.0001 1 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 95.00
CHF 88.35 (7%)
4030748.0005 5 mg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 378.00
CHF 351.54 (7%)

Details

This hexapeptide FRET substrate is derived from the p24/p15 cleavage site of the viral gag-pol poly-protein. A simple, continuous fluorometric assay for HIV protease has been developed, which allows the screening of potential HIV protease inhibitors. Values for Km (2.1 μM) and kcat (7.4 s⁻¹) were calculated from steady-state data at a low concentration of the enzyme. Excitation at 280 nm, emission at > 435 nm.
Catalog Number H-2992
Molecular Formula C₄₃H₆₅N₁₃O₁₁
Relative Molecular Mass 940.07
CAS Registry Number 133233-38-2
Source Synthetic
Storage Conditions -20 ± 5 °C
Keywords HIV protease FRET substrate
Application Infectious Disease
Links / Documents:

Bachem product citations

M.Mondal et al., MedChemComm, 6, 1267 (2015)
D.Duan et al., ACS Chem. Biol., 10, 978 (2015)
J.Agniswamy et al., J. Med. Chem., 58, 5088 (2015)
M.Mondal et al., Angew. Chem. Int. Ed. Engl., 53, 3259 (2014)
H.Zhang et al., J. Med. Chem., 56, 1074 (2013)
F.Benedetti et al., J. Med. Chem., 55, 3900 (2012)
Y.C.Chang et al., J. Med. Chem., 55, 3387 (2012)
A.Blum et al., J. Mol. Biol., 410, 745 (2011)
J.M.Louis et al., Biochemistry, 50, 4786 (2011)
M.W.Chang and B.E.Torbett, J. Mol. Biol., 410, 756 (2011)
T.Luksch et al., ChemMedChem, 5, 443 (2010)
A.Blum et al., J. Med. Chem., 51, 2078 (2008)
J.Bottcher et al., J. Mol. Biol., 383, 347 (2008)
M.J.Giffin et al., J. Med. Chem., 51, 6263 (2008)
S.Geremia et al., ChemMedChem, 1, 186 (2006)
C.Bonini et al., Tetrahedron, 61, 6580 (2005)
F.Benedetti et al., Arkivoc, XIV, 140 (2003)
D.J.Porter et al., Biochemistry, 41, 1302 (2002)
D.J.Porter et al., Biochemistry, 41, 1302 (2002)
D.S.Dauber et al., J. Virol., 76, 1359 (2002)
K.K.Reiling et al., Biochemistry, 41, 4582 (2002)
M.Baca and S.B.Kent, Proc. Natl. Acad. Sci. USA, 90, 11638 (1993)

Product citations

D.J.Porter et al., Biochemistry, 41, 1302 (2002)
M.V.Toth and G.R.Marshall, Int. J. Pept. Protein Res., 36, 544 (1990)

4030748

Enzyme Substrates Inhibitors
Retropepsin